LATOYA RUSSELL: Open Payments
NPI 1285211268 · OTTAWA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 10 payments from 8 companies in 2025. Trend: 2023 $115 · 2024 $179 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $19 |
| Corium, LLC | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: INGREZZA, INVEGA SUSTENNA, REXULTI, Auvelity, ARISTADA, Azstarys, Jornay PM, VRAYLAR.
Industry payments across OH — which companies pay providers there.
